It's How Medicine Should Be®


French German Italian Portuguese Russian

Glioblastoma Multiforme Vaccine Trial

Clinical Trial Title: 
DC Vax-Brain
Clinical Trial Protocol ID: 
Clinical Trial Investigator Name: 
Nina Paleologos, MD
Clinical Trial Protocol Description: 

Vaccine trial for the treatment of glioblastoma multiforme, administered in conjunction with temozolomide and radiation therapy, which is the current, accepted standard of care.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Are 18 to 70 years of age.
  • Have a life expectancy greater than eight weeks.
  • Are willing to consent to tumor tissue sampling prior to surgery.
  • Have a tumor that is unilateral and may involve, but not cross, the corpus callosum.

This is a partial list of eligibility requirements. 

Clinical Trial Area: 
Brain Tumors
Contact Phone: 
(312) 942-4500
Contact Name: 
Amanda Begley